This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to β-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
本发明涉及
辣椒素受体VR1
配体。更具体地说,本发明涉及β-
氨基四氢
萘基
脲,它们是VR1的有效拮抗剂或激动剂,用于治疗和预防哺乳动物的炎症和其他疼痛症状。